RESUMO
INTRODUCTION: Although extracorporeal photopheresis (ECP) is a promising second-line therapy in the treatment of chronic graft-versus-host disease (cGVHD), its use is limited by its high cost. This study aims to describe the clinical evolution of patients who underwent ECP therapy for cGVHD and to perform an economic analysis of the therapy METHODS: This was a case series between 2016 and 2020 describing the clinical response to ECP and a micro-cost analysis of the therapy using time-driven activity-based costing. RESULTS: Six patients underwent ECP for corticosteroid-dependent cGVHD The cost per ECP session is 14,960.90 Brazilian reais (BRL), which primarily consists of the ECP kit with an activator (82.78%), followed by the hospital's physical structure (14.66%), human resources (2.48%) and exams/inputs (0.08%). The number of sessions performed ranged from 2 to 42. The total cost of the therapy per patient ranged from BRL 30,000 to 500,000. CONCLUSION: The response of the patient with cGVHD to treatment with ECP was variable. These micro-costing results can be used to develop remuneration and cost control strategies in hematopoietic stem cell transplantation programs, as well as in further economic studies.
RESUMO
INTRODUCTION: The time elapsed from diagnosis to hematopoietic stem cell transplantation (HSCT) is influenced by numerous factors. In Brazil, patients using the public health system are also dependent on the availability of HSCT-specific beds in the hematology ward. OBJECTIVE AND METHODS: We conducted a cohort study of listed patients who underwent allogeneic HSCT at a Brazilian public hospital to investigate the impact of the waitlist time on post-HSCT survival. RESULTS: The median time from diagnosis to HSCT was 19 months (IQR, 10 - 43), of which 6 months (IQR, 3 - 9) were spent on the waitlist. The time on the waitlist for HSCT appeared to influence mainly the survival of adult patients (≥ 18 years), with an increasing risk according to this time (RR, 3.53 and 95%CI, 1.81 - 6.88 for > 3 and ≤ 6 months; RR 5.86 and 95%CI, 3.26 - 10.53 for > 6 and ≤ 12 months, and; RR 4.24 and 95%CI, 2.32 - 7.75 for > 12 months). CONCLUSION: Patients who remained on the waitlist for less than 3 months had the highest survival (median survival, 856 days; IQR, 131 - 1607). The risk of reduced survival was about 6-fold higher (95%CI, 2.8 - 11.5) in patients with malignancies.
RESUMO
Abstract Introduction Although extracorporeal photopheresis (ECP) is a promising second-line therapy in the treatment of chronic graft-versus-host disease (cGVHD), its use is limited by its high cost. This study aims to describe the clinical evolution of patients who underwent ECP therapy for cGVHD and to perform an economic analysis of the therapy Methods This was a case series between 2016 and 2020 describing the clinical response to ECP and a micro-cost analysis of the therapy using time-driven activity-based costing. Results Six patients underwent ECP for corticosteroid-dependent cGVHD The cost per ECP session is 14,960.90 Brazilian reais (BRL), which primarily consists of the ECP kit with an activator (82.78%), followed by the hospital's physical structure (14.66%), human resources (2.48%) and exams/inputs (0.08%). The number of sessions performed ranged from 2 to 42. The total cost of the therapy per patient ranged from BRL 30,000 to 500,000. Conclusion The response of the patient with cGVHD to treatment with ECP was variable. These micro-costing results can be used to develop remuneration and cost control strategies in hematopoietic stem cell transplantation programs, as well as in further economic studies.
Assuntos
Humanos , Fotoferese , Doença Enxerto-Hospedeiro , Avaliação em Saúde , Custos e Análise de CustoRESUMO
Objetivo: O objetivo deste estudo foi estimar os custos do tratamento do transplante de células--tronco hematopoéticas (TCTH) em um centro de referência no Brasil. Métodos: A população do estudo foi composta por pacientes provenientes da lista de TCTH do Sistema Único de Saúde submetidos ao TCTH em um hospital do sul do Brasil, entre 2016 e 2019. A avaliação de custos foi realizada por meio de um estudo de microcusteio, baseado no Time-Driven Activity-based Costing (TDABC) adaptado para estudos econômicos em saúde e incluiu as seguintes etapas: definição da questão de pesquisa, coleta de dados estruturada e análise estatística dos resultados. Resultados: O custo total do TCTH foi de $ 155.110 ($ 92.794 $ 249.146 USD). O TCTH de doador não aparentado compatível foi mais caro do que o TCTH de doador aparentado compatível. Os principais fatores de custo envolvem complicações pós-transplante, principalmente a ocorrência de infecções. Em relação à composição dos custos, exames e procedimentos representam o maior custo em TCTH (45%). Conclusão: Essas estimativas podem ser aplicáveis a novas avaliações de custo-efetividade do TCTH e ajudar os gestores na tomada de decisão em saúde, especialmente em países de média renda
Objective: The objective of this study was to estimate treatment costs of Hematopoietic stem cell transplantation (HSCT) at a reference center in Brazil. Methods: The study population consisted of patients from the Unified Health System HSCT who underwent HSCT in southern Brazil between 2016 and 2019. Costs were measured using a micro-costing approach, based on Time-Driven Activity-based Costing (TDABC) adapted for economic studies in health and included the following steps: definition of the research question, structured data collection, and statistical analysis of results. Results: The total cost of HSCT was $155,110 ($92,794 $249,146 USD). Matched unrelated donor HSCT was more expensive than matched related donor HSCT. The major cost factors involve post- -transplant complications, mainly the occurrence of infections. Concerning cost composition, exams and procedures represent the largest expense in HSCT (45%). Conclusion: These estimates could be applicable to further evaluations for HSCT cost-effectiveness and help healthcare decision-makers in middle-income countries
Assuntos
Transplante de Células-Tronco Hematopoéticas , Custos e Análise de CustoRESUMO
RESUMO Neste estudo propôs-se desenvolver e validar o conteúdo de um Instrumento de avaliação dos pacientes candidatos à colocação do Cateter Central de Inserção Periférica (CCIP) valvulado, abordando as condições adequadas para seu uso prolongado. Trata-se de uma pesquisa quanti-qualitativa, exploratória e descritiva. A construção do Instrumento ocorreu mediante busca as bases de dados LILACS e PubMed, livros e manuais de capacitação. Para a validação do conteúdo do instrumento foi utilizada a técnica Delphi, em três etapas, com a participação de 11 enfermeiras capacitadas, sendo excluídas as que possuíam a capacitação há menos de um ano ou que não realizavam a técnica há pelo menos um ano. A pesquisa ocorreu no período de março a novembro de 2014. Todas as dimensões incluídas no instrumento inicial obtiveram aprovação de, pelo menos, 72,7%, e duas dimensões atingiram aprovação de 100% dos especialistas. O instrumento foi ajustado quanto à clareza, classificação do perfil do paciente e organização das questões. A versão final do Instrumento possibilitou melhor avaliação e padronização de todas as variáveis que interferem na inserção e manutenção no longo prazo do CCIP valvulado.
RESUMEN El objetivo del estudio fue desarrollar y validar el contenido de un Instrumento de evaluación de los pacientes candidatos a la colocación de Catéter Central de Inserción Periférica (PICC) valvulado, frente a las condiciones adecuadas al uso prolongado. Se trata de una investigación cuanti-cualitativa, exploratoria y descriptiva. La construcción del Instrumento se llevó a cabo a través de la búsqueda en las bases de datos LILACS y PubMed, libros y manuales de capacitación. Para la validez de contenido del instrumento se utilizó la técnica Delphi, en tres etapas, con la participación de 11 enfermeras capacitadas, siendo excluidas del estudio las que poseían la capacitación a menos de un año o que no realizaban la técnica durante al menos un año. La investigación se llevó a cabo entre marzo y noviembre de 2014. Todas las dimensiones incluidas en el instrumento inicial obtuvieron la aprobación de, al menos, el 72,7%, y dos dimensiones alcanzaron la aprobación de 100% de los expertos. El instrumento fue ajustado en cuanto a la claridad, clasificación del perfil del paciente y organización de las preguntas. La versión final del Instrumento permitió una mejor evaluación y estandarización de todas las variables que interfieren en la inserción y en el mantenimiento a largo plazo del PICC valvulado.
ABSTRACT This study proposes to develop and validate the content of an Evaluate Instrument of patients who are candidates to place a valved Peripherally Inserted Central Catheter (PICC), which will discuss the adequate conditions to its long-term use. This is a quanti-qualitative research, with exploratory and descriptive approaches. The construction of the Instrument was supported by searches on LILACS and PubMed databases, as well as books and training manuals. To validate the content of the instrument, the Delphi technique was used, which is subdivided in three stages and with the participation of 11 capacitated nurses, excluding those professionals who were capacitated less than a year ago, or those who did not use the mentioned technique for more than one year. The research took place from March to November 2014. All dimensions included in the initial instrument were approved, with at least 72.7% for a positive score, and two dimensions achieved a 100% approval by the specialists. The instrument was adjusted as suggested in clarity, classification of patient's profile, and organization of questions. The final version of the Instrument enabled better evaluation and standardization of the variables that interfere in the insertion and maintenance of the valved PICC in the long-run.